https://neurosciencenews.com/aud-psychopharmacology-22536/
Apremilast, an FDA-approved drug for the treatment of skin conditions including psoriasis and psoriatic arthritis, triggers increased activity in the nucleus accumbens, a brain area associated with regulating alcohol intake. Apremilast reduced drinking behavi…
Create an account or login to join the discussion